Charleston Hematology Oncology Associates — Charleston, South Carolina

Public research footprint of Charleston Hematology Oncology Associates, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Completed

Stopped or withdrawn

Most-studied conditions

Stage IV Squamous Cell Lung Carcinoma AJCC v7 · Recurrent Squamous Cell Lung Carcinoma · Breast Cancer · Lymphoma

Recently updated registry entries

NCT04458831 — A Prospective, Non-interventional, Multinational, Observational Study With Isatuximab in… (Completed)
NCT04093570 — A Study for Participants Who Participated in Prior Clinical Studies of ASTX727 (Standard… (Enrolling By Invitation)
NCT02785952 — Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Charleston Hematology Oncology Associates?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.